Gritstone bio (GRTS)
(Delayed Data from NSDQ)
$0.48 USD
+0.02 (5.44%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $0.48 0.00 (0.67%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.19 | 13.16% |
Earnings Summary
For their last quarter, Gritstone bio (GRTS) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.26 per share. This reflects a positive earnings surprise of 38.46%. Look out for GRTS's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 42.42%.
Earnings History
Price & Consensus
Zacks News for GRTS
Novavax (NVAX) Misses Q2 Earnings and Revenue Estimates
GRTS: What are Zacks experts saying now?
Zacks Private Portfolio Services